B Cell Responses in COVID-19

NCT06891170 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2025-04-30

No results posted yet for this study

Summary

In this study, we will develop techniques to optimize the in vitro production of human monoclonal antibodies.

Conditions

  • COVID 19

Sponsors & Collaborators

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-07
Primary Completion
2024-10-14
Completion
2025-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06891170 on ClinicalTrials.gov